Complement Factor D — Drug Target
All drugs that target Complement Factor D — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Complement Factor D Inhibitor · Complement Factor D inhibitor
Marketed (1)
- DANICOPAN · Complement Factor D Inhibitor · Other
Danicopan is a selective inhibitor of complement Factor D, preventing the cleavage of Factor B and the formation of the C3 convertase in the alternative complement pathway.
Phase 3 pipeline (1)
- CYB704 · Sandoz · Complement Factor D inhibitor · Immunology
CYB704 is a selective inhibitor of complement factor D that reduces complement cascade activation and downstream inflammatory responses.